Literature DB >> 23108142

Tissue damage-associated "danger signals" influence T-cell responses that promote the progression of preneoplasia to cancer.

Ying He1, Jikun Zha, Yamin Wang, Wenhua Liu, Xuanming Yang, Ping Yu.   

Abstract

T-cell responses may be shaped by sterile "danger signals" that are constituted by damage-associated molecular patterns (DAMP). However, whether and what type of adaptive immune responses are triggered in vivo by DAMPs induced by tumor progression are not well characterized. In this study, we report that the production of HMGB1, an established DAMP released by dying cells, was critical for tumor progression in an established mouse model of prostate cancer. HMGB1 was required for the activation and intratumoral accumulation of T cells that expressed cytokine lymphotoxinα(1)β(2) (LT) on their surface. Intriguingly, these tumor-activated T cells recruited macrophages to the lesion and were essential to promote the preneoplasia to invasive carcinoma in an LTβ receptor (LTβR)-dependent manner. Taken together, our findings suggest that the release of HMGB1 as an endogenous danger signal is important for priming an adaptive immune response that promotes malignant progression, with implications for cancer prevention and therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23108142     DOI: 10.1158/0008-5472.CAN-12-2704

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

Review 1.  Post-translational modifications of high mobility group box 1 and cancer.

Authors:  Seidu A Richard; Yuanyuan Jiang; Lu Hong Xiang; Shanshan Zhou; Jia Wang; Zhaoliang Su; Huaxi Xu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 2.  Innate immunity for better or worse govern the allograft response.

Authors:  Leo E Otterbein; Zhigang Fan; Maria Koulmanda; Thomas Thronley; Terry B Strom
Journal:  Curr Opin Organ Transplant       Date:  2015-02       Impact factor: 2.640

3.  Distinct dendritic cell subsets dictate the fate decision between effector and memory CD8(+) T cell differentiation by a CD24-dependent mechanism.

Authors:  Taeg S Kim; Stacey A Gorski; Steven Hahn; Kenneth M Murphy; Thomas J Braciale
Journal:  Immunity       Date:  2014-03-13       Impact factor: 31.745

Review 4.  Out of the frying pan and into the fire: damage-associated molecular patterns and cardiovascular toxicity following cancer therapy.

Authors:  Nicole S Klee; Cameron G McCarthy; Patricia Martinez-Quinones; R Clinton Webb
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-09-15

Review 5.  Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics.

Authors:  Abhishek D Garg; Sanket More; Nicole Rufo; Odeta Mece; Maria Livia Sassano; Patrizia Agostinis; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-10-04       Impact factor: 8.110

6.  Siglec-G represses DAMP-mediated effects on T cells.

Authors:  Tomomi Toubai; Corinne Rossi; Katherine Oravecz-Wilson; Cynthia Zajac; Chen Liu; Thomas Braun; Hideaki Fujiwara; Julia Wu; Yaping Sun; Stuart Brabbs; Hiroya Tamaki; John Magenau; Pang Zheng; Yang Liu; Pavan Reddy
Journal:  JCI Insight       Date:  2017-07-20

7.  A novel function of API5 (apoptosis inhibitor 5), TLR4-dependent activation of antigen presenting cells.

Authors:  Young Seob Kim; Hyun Jin Park; Jung Hwa Park; Eun Ji Hong; Gun-Young Jang; In Duk Jung; Hee Dong Han; Seung-Hyun Lee; Manh-Cuong Vo; Je-Jung Lee; Andrew Yang; Emily Farmer; T-C Wu; Tae Heung Kang; Yeong-Min Park
Journal:  Oncoimmunology       Date:  2018-08-15       Impact factor: 8.110

8.  TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells.

Authors:  Hongliang Fang; Bing Ang; Xinyun Xu; Xiaohui Huang; Yanfeng Wu; Yanping Sun; Wenying Wang; Nan Li; Xuetao Cao; Tao Wan
Journal:  Cell Mol Immunol       Date:  2013-12-23       Impact factor: 11.530

9.  Life after death: targeting high mobility group box 1 in emergent cancer therapies.

Authors:  Z Sheng Guo; Zuqiang Liu; David L Bartlett; Daolin Tang; Michael T Lotze
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

Review 10.  Danger signalling during cancer cell death: origins, plasticity and regulation.

Authors:  A D Garg; S Martin; J Golab; P Agostinis
Journal:  Cell Death Differ       Date:  2013-05-17       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.